About
M. Marc Abreu M.D.
- Dr. Abreu undertook an extensive educational path, which included studies in medicine and physics, a residency, specialized training, and postdoctoral research at top universities including Nobel Prize-awarded Indiana University, University of Pittsburgh, Harvard University, and Yale University.
Served as a faculty at both Harvard and Yale Medical Schools, contributing significantly to medical education, patient care and cutting-edge research in the USA. - Made a pioneering discovery at Yale University: the brain thermal tunnel (BTT). This revolutionary finding enabled, for the first time in history, the continuous and non-invasive monitoring of human brain temperature.
- Holds patents for the BTT technology, a testament to his innovative spirit and dedication to advancing medical science.
- Created the first FDA-approved computer system specifically designed to monitor temperature during critical medical procedures, such as surgeries, enhancing patient safety and procedure outcomes.
- Was the first to delineate the radiation signature of the glucose molecule (resulting in U.S. Patent # 7403805).
- His BTT technology was selected by the US Federal Government to receive the qualifying Therapeutic Discovery Project Grant, that includes the technology with the potential to kill cancer in 30 years.
- Crafted State-of-the-Art, Ultra-Precise Brain Thermodynamics Sensor in Collaboration with the U.S. Naval Research Laboratory, Utilizing Advanced Navy Technology.
- While at Harvard University, Dr. Abreu engaged in a collaboration with the U.S. Department of Defense and the U.S. Air Force, focusing on the development of
innovative, cutting-edge lasers equipped with advanced optical resonators.
About
M. Marc Abreu M.D.
- Dr. Abreu undertook an extensive educational path, which included studies in medicine and physics, a residency, specialized training, and postdoctoral research at top universities including Nobel Prize-awarded Indiana University, University of Pittsburgh, Harvard University, and Yale University.
Served as a faculty at both Harvard and Yale Medical Schools, contributing significantly to medical education, patient care and cutting-edge research in the USA. - Made a pioneering discovery at Yale University: the brain thermal tunnel (BTT). This revolutionary finding enabled, for the first time in history, the continuous and non-invasive monitoring of human brain temperature.
- Holds patents for the BTT technology, a testament to his innovative spirit and dedication to advancing medical science.
- Created the first FDA-approved computer system specifically designed to monitor temperature during critical medical procedures, such as surgeries, enhancing patient safety and procedure outcomes.
- Was the first to delineate the radiation signature of the glucose molecule (resulting in U.S. Patent # 7403805).
- His BTT technology was selected by the US Federal Government to receive the qualifying Therapeutic Discovery Project Grant, that includes the technology with the potential to kill
cancer in 30 years. - Crafted State-of-the-Art, Ultra-Precise Brain Thermodynamics Sensor in Collaboration with the U.S. Naval Research
Laboratory, Utilizing Advanced Navy Technology.
While at Harvard University, Dr. Abreu engaged in a
collaboration with the U.S. Department of Defense and
the U.S. Air Force, focusing on the development of
innovative, cutting-edge lasers equipped with advanced
optical resonators.
Cutting-edge
Academic background
Yale School of Medicine
Postdoctoral Fellowship, Anesthesiology (2007)
Yale School of Medicine
Postdoctoral Clinical Fellow (2004)
Yale School of Medicine
Postdoctoral Research Fellow Glaucoma (2003)
University of Pittsburgh School of Medicine
Resident in Ophthalmology and Eye Surgery (1999)
Harvard Medical School
Postdoctoral Fellow, Ophthalmology (1996)
Harvard Medical School
Clinical Fellow, Ophthalmology (1995)
Indiana University School of Medicine
Internal Medicine Resident (1994)
Federal University of São Paulo (UNIFESP)
Ophthalmology Residency Program (1988)
Federal University of São Paulo (UNIFESP)
Doctor of Medicine – MD (1985)
Yale School of Medicine
Postdoctoral Fellowship, Anesthesiology (2007)
Yale School of Medicine
Postdoctoral Research Fellow Glaucoma (2003)
Harvard Medical School
Postdoctoral Fellow, Ophthalmology (1996)
Indiana University School of Medicine
Internal Medicine Resident (1994)
Federal University of São Paulo (UNIFESP)
Doctor of Medicine – MD (1985)
Yale School of Medicine
Postdoctoral Clinical Fellow (2004)
University of Pittsburgh School of Medicine
Resident in Ophthalmology and Eye Surgery (1999)
Harvard Medical School
Clinical Fellow, Ophthalmology (1995)
Federal University of São Paulo (UNIFESP)
Ophthalmology Residency Program (1988)
Carreira Científica
Conheça os trabalhos Científicos realizados pelo Dr. Marc Abreu
Dr. Marc teve seu primeiro artigo científico publicado em 1985 e tem mais de 30 trabalhos entre artigos publicados, pré-print e apresentações em congressos medicos e desenvolveu mais de 116 patentes em 60 diferentes países ao redor do mundo, incluindo Brasil e Estados Unidos.
FAQ
Frequently Asked Questions About Dr. Marc Abreu
Dr. Marc Abreu’s first scientific publication was in 1985 in the field of neuro-ophthalmology, already showcasing his early interest in neurology and the brain. This research was published in the Arquivos Brasileiros de Oftalmologia, a highly respected journal in global medicine (click to read).
Since then, Dr. Abreu has authored over 30 scientific works, including peer-reviewed articles, conference abstracts, and preprints, presented at prestigious medical congresses.
This discovery led to the invention and patent of the Abreu BTT 700 System, which has been FDA-approved. Dr. Marc Abreu serves as the Medical Director of the BTT Medical Institute, where, in addition to cancer patients, he treats individuals with neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, ataxia, Huntington’s disease, motor neuron diseases (ALS), multiple system atrophy, as well as multiple sclerosis, epilepsy, and other neurological disorders. His approach is based on the modulation of brain thermodynamics and thermoregulatory frequencies.
Check out Dr. Marc Abreu's profile on LinkedIn.
M. Marc Abreu, M.D.
Founder and Medical Director at BTT Medical Institute
and CSO, Head of Scientific Research at Brain Tunnelgenix Technologies Corp (BTT Corp).
Units
Dr. Abreu’s Private Practice
BTT Medical Institute South
BTT Medical Institute North
BTT Corp.
Copyright © 2025 BTT Medical Institute – All Rights Reserved. Terms of Use – Privacy Policy